These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24434756)

  • 1. Therapeutic fasting in patients with metabolic syndrome and impaired insulin resistance.
    Stange R; Pflugbeil C; Michalsen A; Uehleke B
    Forsch Komplementmed; 2013; 20(6):421-6. PubMed ID: 24434756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea.
    Kang ES; Yun YS; Park SW; Kim HJ; Ahn CW; Song YD; Cha BS; Lim SK; Kim KR; Lee HC
    Metabolism; 2005 Feb; 54(2):206-11. PubMed ID: 15690315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 codon 72 (Arg72Pro) polymorphism is associated with the degree of insulin resistance in type 2 diabetic subjects: a cross-sectional study.
    Bonfigli AR; Sirolla C; Testa R; Cucchi M; Spazzafumo L; Salvioli S; Ceriello A; Olivieri F; Festa R; Procopio AD; Brandoni G; Boemi M; Marra M; Franceschi C
    Acta Diabetol; 2013 Jun; 50(3):429-36. PubMed ID: 23269546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
    Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
    Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
    Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
    Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Ramadan fasting on some indices of insulin resistance and components of the metabolic syndrome in healthy male adults.
    Shariatpanahi ZV; Shariatpanahi MV; Shahbazi S; Hossaini A; Abadi A
    Br J Nutr; 2008 Jul; 100(1):147-51. PubMed ID: 18053308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
    Shalitin S; Abrahami M; Lilos P; Phillip M
    Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between HOMA-IR and ISI-gly in detecting subjects with the metabolic syndrome.
    Carnevale Schianca GP; Sainaghi PP; Castello L; Rapetti R; Limoncini AM; Bartoli E
    Diabetes Metab Res Rev; 2006; 22(2):111-7. PubMed ID: 16052601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
    Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
    Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
    Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
    Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.
    Huptas S; Geiss HC; Otto C; Parhofer KG
    Am J Cardiol; 2006 Jul; 98(1):66-9. PubMed ID: 16784923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interactions among metabolic syndrome components and homeostasis model assessment of insulin resistance in a middle-aged general population over time.
    Bonora BM; Marescotti M; Marcuzzo G; Avogaro A; Fadini GP
    Metab Syndr Relat Disord; 2015 May; 13(4):171-8. PubMed ID: 25734622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.
    Derosa G; Maffioli P; Ferrari I; Mereu R; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Salvadeo SA
    Horm Metab Res; 2010 Aug; 42(9):663-9. PubMed ID: 20560108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects.
    Matsuhisa M; Yamasaki Y; Emoto M; Shimabukuro M; Ueda S; Funahashi T; Matsuzawa Y
    Diabetes Res Clin Pract; 2007 Jul; 77(1):151-4. PubMed ID: 17081646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance in men with treated hypertension at increased risk for cardiovascular disease: results of a 3-year study.
    Mohteshamzadeh M; Wilkinson R; Thomas SH
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):452-6. PubMed ID: 15831352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.